Australian Clinical Labs
ACL.AX
#7734
Rank
A$0.62 B
Marketcap
A$3.35
Share price
0.00%
Change (1 day)
25.06%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2025: A$0.17

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is A$0.17. In 2025 the company made an earnings per share (EPS) of A$0.17 an increase over its 2024 EPS that were of A$0.12.

EPS history for Australian Clinical Labs from 2021 to 2025

Annual EPS

Year EPS Change
2025A$0.1740.51%
2024A$0.12-32.69%
2023A$0.18-80.47%
2022A$0.91105.25%
2021A$0.44